587 related articles for article (PubMed ID: 29053849)
21. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
[TBL] [Abstract][Full Text] [Related]
22. Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
Pehrson AL; Leiser SC; Gulinello M; Dale E; Li Y; Waller JA; Sanchez C
Eur J Pharmacol; 2015 Apr; 753():19-31. PubMed ID: 25107284
[TBL] [Abstract][Full Text] [Related]
23. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
Ruhé HG; Huyser J; Swinkels JA; Schene AH
J Clin Psychiatry; 2006 Dec; 67(12):1836-55. PubMed ID: 17194261
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Evans VC; Alamian G; McLeod J; Woo C; Yatham LN; Lam RW
CNS Drugs; 2016 May; 30(5):405-17. PubMed ID: 27113464
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
26. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
Levada OA; Troyan AS
J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
[TBL] [Abstract][Full Text] [Related]
27. Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset.
Iovieno N; Papakostas GI; Feeney A; Fava M; Mathew SJ; Iosifescu DI; Murrough JW; Macaluso M; Hock RS; Jha MK
J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34133089
[No Abstract] [Full Text] [Related]
28. Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: A systematic review and meta-analysis.
Pluijms EM; Kamperman AM; Hoogendijk WJ; Birkenhäger TK; van den Broek WW
Aust N Z J Psychiatry; 2021 Apr; 55(4):366-380. PubMed ID: 32900217
[TBL] [Abstract][Full Text] [Related]
29. Dose-Response Relationship in Selective Serotonin and Norepinephrine Reuptake Inhibitors in the Treatment of Major Depressive Disorder: A Meta-Analysis and Network Meta-Analysis of Randomized Controlled Trials.
Rink L; Adams A; Braun C; Bschor T; Kuhr K; Baethge C
Psychother Psychosom; 2022; 91(2):84-93. PubMed ID: 34965534
[TBL] [Abstract][Full Text] [Related]
30. Relative Efficacy and Acceptability of Antidepressant Drugs in Adults With Major Depressive Disorder: Commentary on a Network Meta-Analysis.
Andrade C
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29718600
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.
Fagiolini A; Florea I; Loft H; Christensen MC
J Affect Disord; 2021 Mar; 283():472-479. PubMed ID: 33516560
[TBL] [Abstract][Full Text] [Related]
32. Vortioxetine: A new alternative for the treatment of major depressive disorder.
Salagre E; Grande I; Solé B; Sanchez-Moreno J; Vieta E
Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(1):48-59. PubMed ID: 28800937
[TBL] [Abstract][Full Text] [Related]
33. The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants.
Duan Y; Wei J; Geng W; Jiang J; Zhao X; Li T; Jiang Y; Shi L; Cao J; Zhu G; Zhang K; Yu X
J Affect Disord; 2019 Sep; 256():1-7. PubMed ID: 31154087
[TBL] [Abstract][Full Text] [Related]
34. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2-year long-term nation-wide population-based study emulating a randomized trial.
Kessing LV; Ziersen SC; Andersen FM; Gerds T; Budtz-Jørgensen E
Acta Psychiatr Scand; 2024 May; 149(5):378-388. PubMed ID: 38379028
[TBL] [Abstract][Full Text] [Related]
35. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis.
Rocha FL; Fuzikawa C; Riera R; Hara C
J Clin Psychopharmacol; 2012 Apr; 32(2):278-81. PubMed ID: 22367652
[TBL] [Abstract][Full Text] [Related]
36. Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults.
Zhang X; Cai Y; Hu X; Lu CY; Nie X; Shi L
Front Psychiatry; 2022; 13():922648. PubMed ID: 35815048
[TBL] [Abstract][Full Text] [Related]
37. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.
De Vries C; Gadzhanova S; Sykes MJ; Ward M; Roughead E
Drug Saf; 2021 Mar; 44(3):291-312. PubMed ID: 33354752
[TBL] [Abstract][Full Text] [Related]
38. Cognitive function following a major depressive episode: a systematic review and meta-analysis.
Semkovska M; Quinlivan L; O'Grady T; Johnson R; Collins A; O'Connor J; Knittle H; Ahern E; Gload T
Lancet Psychiatry; 2019 Oct; 6(10):851-861. PubMed ID: 31422920
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
40. Sexual dysfunction associated with major depressive disorder and antidepressant treatment.
Clayton AH; El Haddad S; Iluonakhamhe JP; Ponce Martinez C; Schuck AE
Expert Opin Drug Saf; 2014 Oct; 13(10):1361-74. PubMed ID: 25148932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
